Replication protein A (RPA) is a heterotrimeric, single-stranded DNA (ssDNA)-binding complex comprised of 70 kDa (RPA1), 32 kDa (RPA2), and 14 kDa (RPA3) subunits that is essential for DNA replication, recombination, and repair in eukaryotes. In addition, recent studies using vertebrate model systems have suggested an important role for RPA in the initiation of cell cycle checkpoints following exposure to DNA replication stress. Specifically, RPA has been implicated in the recruitment and activation of the ATM-Rad3-related protein kinase, ATR which, in conjunction with the related kinase, ATM (ataxia-telangiectasia-mutated), transmits checkpoint signals via the phosphorylation of downstream effectors. However, the requirement of RPA for ATR recruitment and activation is controversial and the cellular consequences of RPA functional deficiency have not been investigated. In this report, we have explored the effects of RPA insufficiency on DNA replication, cell survival, and ATM/ATRdependent signal transduction in response to genotoxic stress. RNA interference-mediated suppression of RPA1 caused a slowing of S phase progression, G 2 /M cell cycle arrest, and apoptosis in HeLa cells. RPA-deficient cells demonstrated high levels of spontaneous DNA damage and constitutive activation of ATM, which was responsible for the terminal G 2 /M arrest phenotype. Surprisingly, we found that neither RPA1 nor RPA2 were essential for the HU-or UV-induced phosphorylation of the ATR substrates CHK1 and CREB. These findings reveal that RPA is required for genomic stability and suggest that activation of ATR can occur through RPA-independent pathways in response to genotoxic stress.
INTRODUCTION
Replication protein A (RPA) is a trimeric complex composed of 70 kDa (RPA1), 32 kDa (RPA2), and 14 kDa (RPA3) subunits that is essential for DNA replication in all organisms (1).
RPA represents the major cellular single-stranded DNA (ssDNA)-binding activity in eukaryotic cells and coats ssDNA filaments stoichiometrically in vitro (1) . Through its binding and stabilization of ssDNA, RPA facilitates the unwinding and destabilization of double-stranded DNA (dsDNA), which represents a critical step during DNA replication, recombination, and repair. The major DNA-binding activity of RPA resides within the 70 kDa RPA1 subunit, which contains a centrally-positioned, high affinity, bipartite DNA-binding domain (DBD) and a lowaffinity carboxyl-terminal DBD (1, 2) . The RPA2 protein also contains a DBD, as well as a phosphorylation site-rich amino terminus that may regulate RPA activity in response to cell cycle phase transitions and DNA damage. Kinases implicated in the phosphorylation of RPA2 include cyclin-dependent kinases, and members of the PI3 kinase-related kinase superfamily, including DNA-dependent protein kinase (DNA-PK), ataxia-telangiectasia-mutated (ATM), and ATM/Rad3-related (ATR) (3) (4) (5) (6) (7) . DNA-PK, ATM, and ATR are serine/threonine-glutamine (S/T-Q)-directed kinases with overlapping substrate specificities that regulate DNA repair, apoptosis, and cell cycle checkpoint responses to genotoxic stimuli (8, 9) . At least two S/T-Q residues of RPA2 (Thr-21 and Ser-33) are phosphorylated by DNA-PK, and most likely ATM and ATR, in vitro and within intact cells in response to DNA damage (4, 7, 10, 11) . The biochemical functions of individual RPA2 S/T-Q sites are not well understood. However, DNA damage-induced phosphorylation of RPA2 correlates with decreased binding of RPA to p53 (12, 13) , suggesting that modulation of protein-protein interactions represents one functional endpoint.
In addition to its role in the maintenance and processing of ssDNA, RPA has been implicated as a regulator of DNA damage-induced cell cycle checkpoints. Hypomorphic mutations in RPA1 are associated with hypersensitivity to DNA-damaging agents and cell cycle checkpoint defects in budding and fission yeasts (14, 15) . Immunodepletion of RPA from Xenopus oocytes abrogates an aphidicolin-induced DNA replication checkpoint, which functions to suppress mitosis in the presence of incompletely replicated DNA (16) . Using the Xenopus system it was also shown that RPA is required for the suppression of DNA synthesis in response to DNA strand breaks (17) . The requirement of RPA for checkpoint activation in Xenopus extracts mirrors that for ATR (17) (18) (19) , implying a functional interaction between these two proteins during the initiation of checkpoint signals. Consistent with this notion, RPA is required for the association of ATR with chromatin in the Xenopus system, suggesting that RPA recruits ATR, either directly or indirectly, to sites of genetic damage (16, 20) . Mammalian RPA was found to promote the chromatin association of ATR in vitro via the ATR-interacting protein, ATRIP (21) .
Furthermore, in that study it was concluded that RPA is required for the ATR-mediated phosphorylation of its effector kinase, CHK1, after exposure to hydroxyurea (HU) or UV light.
However, it is clear that ATR also contains an intrinsic, RPA-independent, DNA binding activity (21) (22) (23) and the quantitative requirement of RPA for the chromatin association of ATR-ATRIP complexes in vitro, and for ATR activation in vivo, remains an unsettled matter. In addition, although RPA has been extensively studied in vitro, the cellular consequences of RPA functional deficiency have yet to be explored in mammalian cells.
In this report we have explored the genetic requirement of RPA for DNA replication, survival, and cell cycle checkpoint function in human cells. We demonstrate that RPA deficiency causes spontaneous DNA damage, apoptosis, and the induction of an ATM-dependent G 2 /M checkpoint. Surprisingly, we found that neither the RPA1 nor RPA2 subunits were required for ATRdependent substrate phosphorylation in DNA-damaged HEK 293T cells. Our findings demonstrate a requirement for RPA in the maintenance of genomic integrity, and suggest that ATR is activated independently of RPA in response to genotoxic stress.
EXPERIMENTAL PROCEDURES
Cell culture and antisera-HEK 293T and HeLa cells were maintained in Eagle's minimum essential medium containing 10% FCS. Antibody suppliers included: GeneTex (α-ATM), Oncogene Research (α-RPA1, α-RPA2, and α-BrdU), Santa Cruz Biotechnology (α-CHK1 (G-4), Upstate Biotechnology (α-tubulin, and α-pH2AX-139), Cell Signaling (α-CREB), Affinity Bioreagents (α-ATR), and R&D Systems (α-pATM-1981 and α-pCHK1-317). The α-pCREB-121 antibody has been previously published (24) .
Transfections and protein analysis-Transfection-ready siRNA duplexes were purchased from Dharmacon Research. siRNAs used in this study included: RPA1 (5'-AACUGGUUGACGAAAGUGGUG-3'), ATR (5'-AACCCGCGUUGGCGUGGUUGA-3'), RPA2, and ATM. The RPA2 and ATM siRNAs represented mixtures of four distinct RNA duplexes (SmartPool, Dharmacon). Three micrograms of siRNA was used for each transfection using the calcium phosphate DNA precipitation procedure. Cells were harvested 48-72 h later and extracts prepared as described (24) . Seventy-five micrograms of total protein was separated on 10% SDS-PAGE gels and transferred to Immobilon PVDF membranes (Millipore).
Membranes were blocked in Tris-buffered saline containing 0.2% Tween-20 (TBS-T) and 5% dried milk and incubated overnight at 4° C with the indicated primary antibodies diluted in blocking solution. After washing, the blots were incubated with HRP-conjugated sheep antimouse or goat anti-rabbit secondary antibodies (Jackson) and developed using SuperSignal chemillumiscent substrate (Pierce). 
RESULTS AND DISCUSSION
Phenotypic characterization of RPA1-deficient cells-We used an RPA1-specific smallinterfering RNA (siRNA) to suppress RPA1 expression in HEK 293T or HeLa cells.
Immunoblotting confirmed that the expression of RPA1 was reduced by more than 90% in both cell lines within 48 h of transfection, whereas the expression of RPA2 was unaffected (Fig. 1A) .
Transfection of a scrambled (SCR) siRNA had no effect on RPA1 expression. To examine the impact of RPA1 dosage suppression on DNA synthesis and cell cycle progression, we This analysis revealed that ATM was autophosphorylated on Ser-1981 following transfection with RPA siRNA (Fig. 2C) . Although autophosphorylation was detectable by 48 h, it was much more pronounced at 72 h post-transfection, which is consistent with the time course of DSB induction shown in Fig. 2A . The level of ATM autophosphorylation was about three-fold less than that induced by 10 Gy of IR. From the combined findings, we conclude that prolonged RPA1 deficiency induces spontaneous DNA damage, activates ATM, and induces an ATMdependent G 2 /M cell cycle checkpoint in HeLa cells.
Effects of RPA siRNA on ATM and ATR activation following DNA damage-We next sought to
determine the relative requirement of RPA for the activation of ATM and ATR following DNA damage. The observation that ATM became autophosphorylated during prolonged RPA1 deficiency suggested that ATM activation does not require RPA. We formally tested this possibility and found that RPA1 siRNA had no effect on the autophosphorylation of ATM on Ser-1981 following exposure to 5 Gy of IR, validating that RPA is not required for the activation of ATM in response to this stimulus (Fig. 3) .
To determine the requirement of RPA for ATR activation, we examined the effects of siRNAs specific for RPA1 or RPA2 on the ATR-dependent phosphorylation of CHK1 on Ser-317 (30, 31) . For comparative purposes, an ATR siRNA was employed as a side-by-side control.
Interestingly, during the course of these experiments, we found that an RPA2 siRNA caused the coordinate down-regulation of RPA1, but not vice versa (Fig. 4A) . The basis for this phenomenon is not known, but it was observed using several RPA2 siRNAs and may reflect a role for RPA2 as an RPA1 stability determinant. Immunoblot analysis using a CHK1 Ser-317 phospho-specific antibody revealed that neither RPA2 nor RPA1 siRNAs substantially inhibited the phosphorylation of CHK1 on Ser-317 following exposure of HEK 293T cells to HU (3 mM), UV light (25 J/m 2 ), or IR (10 Gy) (Fig. 4B ). This lack of effect was probably not due to incomplete RPA1 or RPA2 suppression, as the levels of both proteins were drastically reduced 48 h after siRNA transfection (Fig. 4A ). In the same experiment, an ATR siRNA suppressed CHK1 phosphorylation in response to all three stimuli (Fig. 4B) . From this experiment we conclude that CHK1 phosphorylation on Ser-317 in response to HU, UV light, and IR is ATR dependent, but RPA independent.
The requirement of RPA for the DNA damage-induced phosphorylation of other ATR substrates was also explored. The cyclic AMP response element-binding protein (CREB) is a transcription factor that is phosphorylated by ATM in vivo on Ser-121 in response to IR (24) . We have also
shown that both ATM and ATR phosphorylate CREB on Ser-121 in vitro (Ref. 24 and data not shown). In support of a role for ATR as a mediator of CREB phosphorylation in vivo, we found that an ATR siRNA abolished the HU-and UV-induced phosphorylation of the Ser-121 residue (Fig. 4C) . In contrast, transfection with RPA1 or RPA2 siRNAs had no effect on CREB phosphorylation in response to either stimulus. Thus, like CHK1, the UV-and HU-induced phosphorylation of CREB is ATR dependent, but RPA independent. Finally, in this experiment we also observed that the IR-induced phosphorylation of CREB was unaffected by an ATR siRNA, which contrasts with the CHK1 result (compare Figs. 4B and 4C ). However, this finding is consistent with our previous report demonstrating that IR-induced phosphorylation of CREB is ATM dependent (24) .
In this study we have demonstrated that RPA is required for genomic integrity in mammalian cells; RPA insufficiency causes spontaneous DSBs, ATM-dependent G 2 /M arrest, and apoptotic cell death. The mechanism of DNA damage induction following RPA suppression is unknown, but most likely involves the execution of an aberrant DNA replication cycle after RPA levels have declined below a critical threshold level. Consistent with this possibility, DSB induction and ATM activation were observed 72-96 h after RPA1 siRNA transfection, which is 24-48 h after RPA1 expression reached its minimum. It is possible that DSB induction reflects a structural role for RPA in protecting ssDNA filaments from spontaneous strand breakage. A non-exclusive possibility is that, in the prolonged absence of RPA, ssDNA present at replication forks is converted into DSBs through failed cycles of recombination. RPA functionally interacts with the enzymatic machinery of recombination, including RAD51, RAD52, and BLM, a helicase that contributes to the resolution of recombination intermediates present at stalled replication forks (32) (33) (34) (35) . It is therefore conceivable that DSBs arise in RPA-deficient cells secondarily to gross DNA recombination abnormalities.
In our hands an RPA1 siRNA did not substantially inhibit the IR-induced autophosphorylation of ATM, nor did RPA1 or RPA2 siRNAs suppress ATR-dependent substrate phosphorylation in response to HU or UV light. The RPA independence of ATR activation was somewhat surprising given several recent reports implicating RPA as an upstream regulator of the ATR pathway in Xenopus and mammalian cells (16, 20, 21) . Nevertheless, we failed to observe inhibitory effects of RPA1 or RPA2 siRNAs on the HU-or UV-induced phosphorylation of three ATR substrates: CHK1, CREB, and RAD17 ( Fig. 4 and unpublished results) . In these same experiments, an ATR siRNA strongly inhibited substrate phosphorylation, even though the ATR siRNA was less efficacious than either the RPA1 or RPA2 siRNAs (Fig. 4) . Because of inherent caveats associated with RNAi-based experiments, we cannot rule out the possibility that a low threshold level of RPA was sufficient to activate ATR in our experiments. However, at minimum, our findings indicate that a reduction in RPA dosage does not cause a corresponding linear decrease in ATR activity, as assessed by phosphorylation of CHK1 on Ser-317 and CREB on Ser-121. This conclusion is at odds with recent reports that also used RNAi to implicate RPA in the ATR-dependent phosphorylation of CHK1 in HeLa cells (21, 36) . 
